Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target IL17A
Clinical data
ATC code none
CAS Number 89957-37-9
ChemSpider none
Chemical and physical data
Formula C6454H9964N1718O2030S44
Molar mass 145.4 kg/mol

Perakizumab (INN) is a humanized monoclonal antibody designed for the treatment of arthritis.[1] It binds to IL17A and acts as an immunomodulator.[2]

This drug was developed by Genentech/Roche.


  1. Statement On A Nonproprietary Name Adopted By The USAN Council - Perakizumab, American Medical Association.
  2. World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107" (PDF). WHO Drug Information. 26 (2).

This article is issued from Wikipedia - version of the 6/4/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.